alert icon Important Updates + Notice of Vendor Data Event

Coming to a Cleveland Clinic location?
Hillcrest Cancer Center check-in changes
Cole Eye entrance closing
Visitation, mask requirements and COVID-19 information

Notice of Intelligent Business Solutions data event
Learn more

Patricia Klaas, Ph.D.

Patricia Klaas, Ph.D.
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Center for General Neurology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Children & Adolescents Only
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Center for Pediatric Epilepsy
  • Clinical Trials
  • Cognitive/neuropsychological Evaluations
  • Evaluation of Cognitive Changes Associated with Epilepsy
  • Neuropsychological Evaluation
  • Pediatric Neuropsychology
  • Pediatric Neuroscience
View all 7 Treatment & Services +

Specialty in Diseases & Conditions

  • Brain Cancer (Brain Tumor)
  • Brain Hemorrhage
  • Brain Metastases
  • Cerebrovascular Disease
  • Cognitive Disorders
  • Dyslexia
  • Encephalitis
  • Encephalopathy
  • Epilepsy
  • Epilepsy in Children
  • Hydrocephalus
  • Neurocognitive Disorders
  • Neurofibromatosis
  • Shaken Baby Syndrome
  • Spina Bifida
  • Traumatic Brain Injury
View all 16 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Patricia Klaas, Ph.D.

Patricia Klaas, PhD is a Pediatric Neuropsychologist who has been in practice since 2000. She has expertise in neurodevelopmental and disorders/injuries of the Central Nervous System. Her graduate training was at the oldest free standing clinical neuropsychology program in the country at the University of Houston. During her graduate training she worked in a number of placements within the Texas Medical Center of Houston including Baylor Department of Neurosurgery, University of Texas-Houston Health Sciences Center Departments of Neurosurgery and Pediatrics, and Bluebird Circle Clinic of Pediatric Neurology. Internship was at University of Arizona Medical Center Department of Psychiatry and Post-Doctoral Fellowship was at University of Texas-Houston Health Sciences Center Department of Neurosurgery. She is currently involved in research looking at medication effects on cognition in children with ESES, genetic contributions to cognitive functioning in children with PTEN Hamartoma Syndrome and long term outcomes in infants who have been treated for medulloblastoma. 

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - University of Texas Health Science Center at Houston
Houston, TX USA

Graduate School - University of Houston
Clinical Neuropsychology
Houston, TX USA

Internship - University Medical Center-Tucson
Clinical Psychology
Tucson, AZ USA

Graduate School - University of Houston
Houston, TX USA

Undergraduate - University of Illinois at Chicago
Chicago, IL USA

Additional Training

Professional Highlights

Specialty Interests

Epilepsy, head injury, neurodevelopmental disorders, neuropsychology, pediatric neuropsychology, epilepsy and behavior research interest, evaluation of cognitive changes associated with epilepsy, memory executive functioning, neuropsychological assessment, neurodevelopmental disorders, head injury

Awards & Honors

Innovations & Patents


  • International Neuropsychological Society
  • Cognitive Neuroscience Society
  • Cleveland Psychological Association
  • Houston Neuropsychological Society
Research & Publications

Research & Publications

See publications for Patricia Klaas, Ph.D..

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/17/2022, Dr. Klaas has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top